productsShow.asp
 
PRODUCT

Address: Huangpu district Science town, Guangzhou, Kaiyuan Dadao no.188, G building, room 405-406

Phone: 020-87658152

Fax: 020-87658152-803

Home > Products > Individual Target Drug > Article
HLA-B*1502 DETECTION
PG1502 Detection Kit
DETAILS
Relating to Drug: Carbamazepine & Phenytoin


HLA-B*1502 Detection
RT-PCR & SYBR Green based detection method: each sample requires only 2 PCR rxns for detecting of HLA-B*1502 and Internal Control. Analysis is based on Ct values. A complete kit version is CE marked and has IVD approval from Department of Health, Taiwan.

HLA-B*1502 Detection FastGel Test
PCR based detection method: each sample requires only 1 PCR rxn for detection of HLA-B*1502 and Internal Control. Analysis is based on gel electrophoresis or Agilent™ BioAnalyzer™.


Product Features

  • Required only hours from blood sample to results.
  • Designed for easy operation & analysis.
  • Validated accuracy with 4500+ patients samples* & DNA sequencing.
  • Protected by US, Europe & world wide patents.
  • Product Sheets available in right hand column.
  • Mix & Match design.
Regulatory Status
HLA-B*1502 Detection HLA-B*1502 Detection FastGel Test
CE IVD CE IVD
Taiwan IVD Taiwan IVD
China IVD  
US ASR  

Many studies have demonstrated the strong association of Human Leukocyte Antigen (HLA-B*1502) and carbamazepine, phenytoin, & oxcarbazepine induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Individuals that use DNA tests to determine their HLA genotypes prior to taking these drugs can reduce their risks of developing SJS/TEN by as high as 1300 times.


Previous:HLA-B*5801 DETECTION Next:No

商务客服:
点击这里给我发消息

技术客服:
点击这里给我发消息

服务时间:
9:00-17:30(工作日)